scholarly article | Q13442814 |
P50 | author | Nizar N Jarjour | Q88330675 |
P2093 | author name string | Bruce S Bochner | |
Elizabeth A Kelly | |||
Mats W Johansson | |||
Christopher L Nguyen | |||
P2860 | cites work | Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma | Q39377433 |
The Biology of Eosinophils and Their Role in Asthma | Q39438308 | ||
Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins. | Q41207923 | ||
Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma | Q41370706 | ||
Dissection of the hyperadhesive phenotype of airway eosinophils in asthma | Q41975092 | ||
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia | Q46098864 | ||
Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β2-integrin-dependent function in human eosinophils | Q46309701 | ||
Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases | Q46484443 | ||
Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma. | Q47786031 | ||
IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation. | Q48014771 | ||
IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration | Q48318859 | ||
Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. | Q50774303 | ||
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. | Q51699174 | ||
Immunophenotypic study of basophils by multiparameter flow cytometry | Q81240091 | ||
Eosinophil beta 1 integrin activation state correlates with asthma activity in a blind study of inhaled corticosteroid withdrawal | Q83917010 | ||
IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils | Q24631401 | ||
Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways | Q24685595 | ||
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils | Q28138424 | ||
Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis | Q28212692 | ||
Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge | Q28215560 | ||
Eosinophil Activation Status in Separate Compartments and Association with Asthma | Q33785627 | ||
IL-5 induces suspended eosinophils to undergo unique global reorganization associated with priming | Q33799642 | ||
A role for eosinophils in airway remodelling in asthma | Q34550355 | ||
Safety of and cellular response to segmental bronchoprovocation in allergic asthma | Q34558188 | ||
Eosinophils: changing perspectives in health and disease | Q35170969 | ||
Activation of beta1 integrins on blood eosinophils by P-selectin | Q35528037 | ||
Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis. | Q35612914 | ||
Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma | Q35813671 | ||
Expression and preliminary functional analysis of Siglec-F on mouse macrophages | Q35946412 | ||
Flow Cytometric Analysis of Myeloid Cells in Human Blood, Bronchoalveolar Lavage, and Lung Tissues | Q36549074 | ||
Anti-IL-5 attenuates activation and surface density of β(2) -integrins on circulating eosinophils after segmental antigen challenge. | Q36630280 | ||
"Siglec"ting the allergic response for therapeutic targeting | Q36843245 | ||
Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge | Q36980346 | ||
Mepolizumab and exacerbations of refractory eosinophilic asthma | Q37711391 | ||
Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives | Q38613170 | ||
Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells | Q38696593 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 1 | |
P304 | page(s) | 16-28 | |
P577 | publication date | 2018-06-07 | |
P1433 | published in | International Archives of Allergy and Immunology | Q2189251 |
P1476 | title | Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge | |
P478 | volume | 177 |
Q98237564 | A FACS-based approach to obtain viable eosinophils from human adipose tissue |
Q92547616 | AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice |
Q60939538 | Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice |
Q60305285 | Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions |
Search more.